Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Clinical trial NCT00290342 · COMPLETED

Trial details

NCT number: NCT00290342
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Acellular Pertussis Diphtheria

Start date: 2006-01-01
Primary completion: 2007-01-01
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.